University of Wisconsin
School of Medicine and Public Health

Sumona Saha, MD, MS

ASSOC PROFESSOR (CHS)

GASTROENTEROLOGY & HEPATOLOGY Faculty

UW MED FNDTN CENTENNIAL BLDG
1685 HIGHLAND AVE
MADISON, WI 53705-2281

(608) 263-1995

education

  • Brown-Dartmouth Medical Program, Alpert School of Medicine of Brown University, Providence, Rhode Island – MD
  • Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts – Residency in Internal Medicine
  • Rhode Island Hospital/Alpert Medical School of Brown University, Providence, Rhode Island– Fellowship in Gastroenterology (with Special Concentration and Focus on Women’s Gastrointestinal Functions and Disorders)
  • University of Wisconsin–Madison - MPH

professional activities

Dr. Sumona Saha is a faculty member in the Division of Gastroenterology and Hepatology within the Department of Medicine. She is the lead physician at UW Health Inflammatory Bowel Disease Clinic and the Director of the Gastrointestinal Disorders in Pregnancy Clinic and the Director of the sub-fellowship in Inflammatory Bowel Disease within the Gastroenterology fellowship program. Dr. Saha is a member of the Crohn’s and Colitis Foundation and the American Gastroenterological Association, and a Charter member of the AGA’s Academy of GI and Liver Educators Advisory Board.

clinical specialties

Dr. Saha is the first physician in the country to complete a training program in gastroenterology with a specific focus on women's health. Her clinical interests are in inflammatory bowel disease and GI disorders in pregnancy.

research interests

Dr. Saha was a recipient of the Building Interdisciplinary Research Careers in Women's Health K1-12 award.  She has conducted multiple studies evaluating the impact of inflammatory bowel disease (IBD) on various aspect of women's health including menstrual function, body image and sexual function.  She has also investigated fertility issues in patients with IBD. She is the site principal investigator for several longitudinal, observational studies in patients with IBD as well as for several clinical trials involving novel therapies for IBD.